Real-world analysis of the use of lenvatinib in differentiated thyroid cancers

INTRODUCTION: Lenvatinib is one of the approved treatments for radioiodine-refractory differentiated thyroid cancers. However, there is very limited data from India on real-world efficacy and adverse events of Lenvatinib and hence this analysis was performed. METHODS: This was a retrospective analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Peelay, Zoya, Parekh, Deevyashali, Patil, Vijay M, Noronha, Vanita, Menon, Nandini, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937066/
https://www.ncbi.nlm.nih.gov/pubmed/36816785
http://dx.doi.org/10.3332/ecancer.2023.1500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937066/
https://www.ncbi.nlm.nih.gov/pubmed/36816785
http://dx.doi.org/10.3332/ecancer.2023.1500

Ejemplares similares